PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 500 | $1,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 17,000 | $43 | 0.00% |
| JPMORGAN CHASE & CO | 2,743 | $7,000 | 0.00% |
| Qube Research & Technologies Ltd | 12,028 | $30,551 | 0.00% |
| Corient Private Wealth LLC | 15,550 | $39,497 | 0.00% |
| NORTHERN TRUST CORP | 112,662 | $286,162 | 0.00% |
External links
This page lists PARATEK PHARMACEUTICALS INC's shareholders in Q1 2023. To view PARATEK PHARMACEUTICALS INC's shareholder history, click here.